CD38 inhibition by apigenin ameliorates mitochondrial oxidative stress through restoration of the intracellular NAD+/NADH ratio and Sirt3 activity in renal tubular cells in diabetic rats

Yoshio Ogura,Munehiro Kitada,Jing Xu,Itaru Monno,Daisuke Koya
DOI: https://doi.org/10.18632/aging.103410
2020-06-07
Aging
Abstract:Mitochondrial oxidative stress is a significant contributor to the pathogenesis of diabetic kidney disease (DKD). We previously showed that mitochondrial oxidative stress in the kidneys of Zucker diabetic fatty rats is associated with a decreased intracellular NAD<sup>+</sup>/NADH ratio and NAD<sup>+</sup>-dependent deacetylase Sirt3 activity, and increased expression of the NAD<sup>+</sup>-degrading enzyme CD38. In this study, we used a CD38 inhibitor, apigenin, to investigate the role of CD38 in DKD. Apigenin significantly reduced renal injuries, including tubulointerstitial fibrosis, tubular cell damage, and pro-inflammatory gene expression in diabetic rats. In addition, apigenin down-regulated CD38 expression, and increased the intracellular NAD<sup>+</sup>/NADH ratio and Sirt3-mediated mitochondrial antioxidative enzyme activity in the kidneys of diabetic rats. <i>In vitro</i>, inhibition of CD38 activity by apigenin or CD38 knockdown increased the NAD<sup>+</sup>/NADH ratio and Sirt3 activity in renal proximal tubular HK-2 cells cultured under high-glucose conditions. Together, these results demonstrate that by inhibiting the Sirt3 activity and increasing mitochondrial oxidative stress in renal tubular cells, CD38 plays a crucial role in the pathogenesis of DKD.
What problem does this paper attempt to address?